Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
Abstract Background The opioid overdose epidemic in Canada and the United States has become a public health crisis - with exponential increases in opioid-related morbidity and mortality. Recently, there has been an increasing body of evidence focusing on the opioid-sparing effects of medical cannabi...
Saved in:
Main Authors: | Cerina Lee (Author), Mu Lin (Author), Karen J. B. Martins (Author), Jason R. B. Dyck (Author), Scott Klarenbach (Author), Lawrence Richer (Author), Ed Jess (Author), John G. Hanlon (Author), Elaine Hyshka (Author), Dean T. Eurich (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada
by: Cerina Dubois, et al.
Published: (2024) -
Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada
by: Cerina Lee, et al.
Published: (2021) -
Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada
by: Cerina Lee, et al.
Published: (2021) -
Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis
by: Jessica M. Round, et al.
Published: (2020) -
Measures of stimulant medications: A population-based study in Alberta, Canada
by: Cerina Dubois, et al.
Published: (2024)